Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,421 to 1,440 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| U24AI118672 | An integrated multiplexed genomic assay for low input clinical samples1 | 4 | 2019 |
| K08CA197966 | Adoptive Cell Therapy with Rejuvenated Antigen-Specific T Cells | 3 | 2019 |
| R00CA204595 | Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity | 3 | 2019 |
| R01AG047156 | Simultaneously boosting both humoral and cellular immunity following vaccination | 3 | 2019 |
| R01AG052608 | Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines | 3 | 2019 |
| R01AI114442 | Epigenetic Regulation of T-cell Exhaustion During Treated Chronic HIV Infection | 3 | 2019 |
| R01CA194511 | Immunotherapy of human bladder cancer | 3 | 2019 |
| R01HL131768 | Statistical methods for analysis of single-cell variability | 3 | 2019 |
| K99CA230195 | Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment | 2 | 2019 |
| P01CA098912 | Prostate Cancer Bone Metastasis Biology and Targeting | 2 | 2019 |
| R00HG007940 | Integrated Analysis & Interpretation of Whole Genome Exome & Transcriptome Sequen | 2 | 2019 |
| R01AI048391 | Role of gamma/delta T cells in Vaccine Induced Immunity | 2 | 2019 |
| R01AR069071 | Role of IL-13 and the IL-13 Associated rs20541 Risk Variant in the Pathogenesis of Psoriasis | 2 | 2019 |
| R01CA187415 | MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma | 2 | 2019 |
| R01CA188900 | Novel immunological biomarkers ovarian cancer prognosis | 2 | 2019 |
| R01DK106491 | Human Group 2 Innate Lympohocyte Cell (ILC2) populations contribute to Hepatic Fibrosis | 2 | 2019 |
| R21AI130800 | Protective and Proinflammatory Immunological Mechanisms behind Liver Ischemia Reperfusion Injury in Marginal Livers | 2 | 2019 |
| R21CA216772 | Physical detection of HLA-C binding peptides to identify and predict immunogenic personal neoepitopes for improving cancer vaccines | 2 | 2019 |
| C06OD028307 | UAHS Sleep Research Center Construction Grant | 1 | 2019 |
| DP2CA247831 | Deciphering the Achilles Heel of Cancer Immunotherapy | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=72